Cancer Tumor Profiling Market Share, High Demand, Future Scope, Recent Trends, Applications, Types, Products, Industry Analysis and Forecast Report 2027
Cancer Tumor
Profiling Market Size – USD 9.89 billion in 2019, Market Growth - CAGR of 9.6%,
Market Trends – Rise in incidence of cancer across the globe, increasing demand
for personalized medicine and Rise in the adoption of the cancer profiling
methods by oncologists.
The rise in the adoption
of the cancer tumor profiling methods by oncologists is seen to drive the
market because of the efficacy of cancer tumor profiling for diagnosis at the
early stage of cancer, which is one factor in boosting the market growth.
However, technical issues with sample collection and storage remain one of the
factors that hinder the growth of the market for the forecast period.
High
investments by companies to launch new products for cancer tumor profiling with
various advancement in the new technique is augmented to propel the market. For
instance, in May 2019, QIAGEN, launched therascreen PIK3CA RGQ PCR Kit as a
companion diagnostic to aid in identifying breast cancer patients.
Get a free exclusive sample of
Cancer Tumor Profiling market report: https://www.emergenresearch.com/request-sample/50
The in-depth report on
the Cancer Tumor Profiling market, along with details on import/export,
consumption and production rate, demand and supply dynamics, competitive
landscape benchmarking, market share, and other key elements, strives to offer
the reader a complete crystal clear understanding of the Cancer Tumor Profiling
business sphere. The individual in-depth study of the prominent players of the
market offers insights into their market position, geographical presence,
production and manufacturing capacity, gross margin, revenue generation, and
business expansion strategies.
Key
participants include Caris Life Sciences, Foundation Medicine,
GenomeDX, Genomic Health, Guardant Health, Helomics Corporation, HTG Molecular
Diagnostics, Inc., Nanostring Technologies, Neogenomics Inc., Oxford Gene
Technology, Qiagen N.V., Ribomed Biotechnologies Inc., among others.
Key
Region of the Cancer Tumor Profiling market: North America,
Latin America, Europe, Asia Pacific, and Middle East & Africa.
Do You Have Any Query Or Specific
Requirement? Ask to Our Industry Expert: https://www.emergenresearch.com/purchase-enquiry/50
The Global Cancer Tumor
Profiling Market Research Report 2020 offers an extensive evaluation of the
industry to present the readers with insightful data to help them gain a
competitive edge over other players by capitalizing on the lucrative growth
opportunities and understanding the critical elements of the market. The report
offers a critical overview of the market segment with regards to the market
size, market share, market volume, price analysis, global reach, and financial
standing. The statistical analysis performed for this report indicates the
market is expected to grow at a steady pace throughout the forecast timeline.
Revenue
and cost profit analysis of major player dominating the Cancer Tumor Profiling
market:
The research study
presents an industry-wide summary of the Cancer Tumor Profiling market,
including drivers, constraints, technological advancements, product
developments, limitations, growth strategies, growth prospects, etc. among
others. The report analyzes the market based on different categories, such as
product types, end-user applications, and leading geographical regions.
·
o
Technique Type Outlook (Revenue,
USD Billion; 2017-2027)
§ Genomics
§ Epigenetics
§ Metabolomics
§ Proteomics
o
Technology Outlook (Revenue, USD
Billion; 2017-2027)
§ Immunoassays
§ In
Situ Hybridization
§ Fluorescence
In Situ Hybridization (FISH)
§ Chromogenic
In Situ Hybridization (CISH)
§ Microarray
§ Polymerase
Chain Reaction (PCR)
§ Sequencing
Technologies
§ Next
Generation Sequencing(NGS)
§ Pyro
Sequencing
§ Sanger
Sequencing
§ Other
Technologies
o
Application Outlook (Revenue, USD
Billion; 2017-2027)
§ Research
Application
§ Biomarker
Discovery
§ Personalized
Cancer Medicine
To get a discount on the Global Cancer Tumor
Profiling Market report, visit: https://www.emergenresearch.com/request-discount/50
Table
of Content:
Chapter
1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter
2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter
3. Key Insights
Chapter
4. Cancer Tumor Profiling Market Segmentation & Impact Analysis
4.1. Cancer Tumor Profiling Market Material
Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increase in the
demand for next-generation sequencing technique in cancer profiling
4.2.2.2. Increase in the
use of biomarkers in cancer profiling
4.2.2.3. Rise in incidence
of cancer across the globe
4.2.2.4. Rise in the
adoption of the cancer profiling methods by oncologists
4.2.3. Market restraints analysis
4.2.3.1. High capital
investment
4.2.3.2. Technical issues
with sample collection and storage
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter
5. Cancer Tumor Profiling Market By Technique Type Insights & Trends,
Revenue (USD Million)
5.1. Technique Type Dynamics & Market
Share, 2019 & 2027
5.1.1. Genomics
5.1.2. Epigenetics
5.1.3. Metabolomics
5.1.4. Proteomics
Chapter
6. Cancer Tumor Profiling Market By Technology Insights & Trends Revenue
(USD Million)
6.1. Technology Dynamics & Market
Share, 2019 & 2027
6.1.1. Immunoassays
6.1.2. In Situ Hybridization
6.1.2.1. Fluorescence In
Situ Hybridization (FISH)
6.1.2.2. Chromogenic In
Situ Hybridization (CISH)
6.1.3. Microarray
6.1.4. Polymerase Chain Reaction
(PCR)
6.1.5. Sequencing Technologies
6.1.5.1. Next Generation
Sequencing(NGS)
6.1.5.2. Pyro Sequencing
6.1.5.3. Sanger Sequencing
6.1.6. Other Technologies
Chapter
7. Cancer Tumor Profiling Market By Application Insights & Trends, Revenue
(USD Million)
7.1. Application Dynamics & Market
Share, 2019 & 2027
7.1.1. Research Application
7.1.1.1. Biomarker
Discovery
7.1.1.2. Personalized
Cancer Medicine
7.1.2. Clinical Application
7.1.2.1. Oncological
Diagnostics
7.1.2.2. Prognostics
7.1.2.3. Monitoring and
Treatment
7.1.2.4. Screening
Continue..!
To
know more about the report, visit: https://www.emergenresearch.com/industry-report/cancer-tumor-profiling-market
Thank you for reading our
report. For further information or queries regarding the report or its
customization, please connect with us. Our team will ensure you get a report
well-suited to your needs.
Related
Report:
Personal Care Ingredients Market@
https://www.google.sm/url?q=https://www.emergenresearch.com/industry-report/personal-care-ingredients-market
Yoga Mat Market@ https://www.google.st/url?q=https://www.emergenresearch.com/industry-report/yoga-mat-market
Healthcare Analytics Market@ https://www.google.com.sa/url?q=https://www.emergenresearch.com/industry-report/healthcare-analytics-market
Mammography Workstations Market@ https://www.google.sn/url?q=https://www.emergenresearch.com/industry-report/mammography-workstations-market
Urgent Care Apps Market@ https://www.google.rs/url?q=https://www.emergenresearch.com/industry-report/urgent-care-apps-market
Drug Screening Market@ https://www.google.sc/url?q=https://www.emergenresearch.com/industry-report/drug-screening-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a
growing market research and strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially market-disrupting technologies
that are predicted to become more prevalent in the coming decade.
Contact Us:
Corporate Sales Specialist
Emergen
Research | Web: www.emergenresearch.com
Direct
Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Comments
Post a Comment